Indian pharmaceutical giant Wockhardt is exploring a sale. The company, known for its diverse selection of generic and branded medications, has been facing challenges in recent months. Sources close to the negotiations suggest that Wockhardt is {attracting interest from|being courted by both domestic and international firms. A final decision is ant